# Phase 4 syndrome trials recruiting: 112 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 112 trials in phase 4 for syndrome that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 4 syndrome trials: 112 rows for $5.60, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 2 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-4/syndrome

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 112
- Recruiting or not yet: 112
- Read on: November 19, 2026

## Trials

The 25 newest of 112, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 16, 2026 | NCT07939516 | Individualized Genotype-guided Antiplatelet Therapy in Patients With Acute Coronary Syndrome | Medisch Spectrum Twente | Phase 4 | Not yet recruiting | Acute Coronary Syndromes (ACS), Unstable Angina Pectoris, Myocardial Infarction (MI), STEMI, NSTEMI | 3,120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07939516) |
| October 7, 2026 | NCT07862712 | Assessing Trauma-related Links Between Affective and Metabolic Systems | VA Office of Research and Development | Phase 4 | Not yet recruiting | Posttraumatic Stress Disorder, Metabolic Syndrome, Insulin Resistance | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07862712) |
| September 17, 2026 | NCT07824895 | Mazdutide for Weight Management and Gout in Adults With Obesity | Sponsor not shown (see the record) | Phase 4 | Not yet recruiting | Gout, Obesity (BMI\>30), Hyperuricemia, Metabolic Syndrome | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07824895) |
| September 17, 2026 | NCT07824323 | Early Triple Lipid-Lowering Therapy With Bempedoic Acid After Acute Coronary Syndrome | Taipei Medical University Hospital | Phase 4 | Recruiting | Acute Coronary Syndromes, Dyslipidemia | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07824323) |
| September 2, 2026 | NCT07799779 | Early Intensive Lipid-Lowering With Inclisiran for Plaque Stabilization in Acute Coronary Syndrome | Seoul National University Bundang Hospital | Phase 4 | Not yet recruiting | Acute Coronary Syndromes (ACS) | 294 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07799779) |
| August 13, 2026 | NCT07762170 | Success Rates and Safety of Steroid Injections in Managing Spinal and Sacro-Iliac Pain (CORTisone Injection Spine Study) | Sponsor not shown (see the record) | Phase 4 | Recruiting | Back Pain Lower Back, Neck Pain, Radiculopathy Multiple Sites, Spinal Stenosis Cervicothoracic Region, Spinal Stenosis... | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07762170) |
| July 30, 2026 | NCT07736196 | Aspirin-Free Strategy After 3-6 Month Dual Antiplatelet Therapy in Acute Coronary Syndrome | Assiut University | Phase 4 | Not yet recruiting | Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI), Dual Anti-platelet Therapy | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07736196) |
| July 27, 2026 | NCT07728097 | A Study to Investigate the Effect of Gradual Titration to Optimize Cannabidiol Treatment in Adults With LGS | Jazz Pharmaceuticals | Phase 4 | Not yet recruiting | Lennox-Gastaut Syndrome | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07728097) |
| July 17, 2026 | NCT07711964 | Identifying an Optimal Corticosteroid Dosage Regimen for Acute Respiratory Distress Syndrome | National Taiwan University Hospital | Phase 4 | Recruiting | Acute Respiratory Distress Syndrome (ARDS) | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07711964) |
| July 8, 2026 | NCT07691125 | Phase IV Study of rhGH Injection in Adult Short Bowel Syndrome | Changchun GeneScience Pharmaceutical Co., Ltd. | Phase 4 | Recruiting | Short Bowel Syndrome (SBS) in Adults | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07691125) |
| July 6, 2026 | NCT07684742 | Early Single Antiplatelet Therapy After IVUS-Guided PCI in Acute Coronary Syndrome | Gyeongsang National University Hospital | Phase 4 | Recruiting | Acute Coronary Syndromes, STEMI, NSTEMI, Unstable Angina | 2,200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07684742) |
| July 6, 2026 | NCT07684469 | Comparative Assessment of Inclisiran on Top of Standard of Care Versus Standard of Care Alone for LDL-C Evaluation in Acute Coronary... | Novartis Pharmaceuticals | Phase 4 | Not yet recruiting | Acute Coronary Syndrome | 300 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07684469) |
| July 6, 2026 | NCT07683923 | Spontaneous Coronary Artery Dissection - AntipLatelet Therapy Intensity in Guided coNservative Management (SCAD-ALIGN) Trial | Universitätsklinikum Hamburg-Eppendorf | Phase 4 | Not yet recruiting | SCAD, ACS (Acute Coronary Syndrome) | 3,518 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07683923) |
| June 29, 2026 | NCT07674290 | Real-World Effects of MC4R Agonist Therapy in BBS and Severe Genetic Obesity | Sponsor not shown (see the record) | Phase 4 | Recruiting | Bardet Biedl Syndrome (BBS), Bardet Biedl Syndrome, Bardet-Biedl Syndrome (BBS), Alstrom Syndrome | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07674290) |
| June 29, 2026 | NCT07673965 | Sleep Outcomes and Multidimensional Sleep Assessment - a Randomized Trial of Dolutegravir- vs Doravirine-based Antiretroviral Therapy in... | University of Witwatersrand, South Africa | Phase 4 | Not yet recruiting | HIV (Human Immunodeficiency Virus), Sleep | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07673965) |
| June 8, 2026 | NCT07634393 | Intravenous Metoclopramide Versus Intravenous Acetaminophen for Acute Concussion Treatment | Montefiore Medical Center | Phase 4 | Not yet recruiting | Concussion Post Syndrome, Head Trauma Injury | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07634393) |
| May 29, 2026 | NCT07612774 | CAPRA-EVO: a Randomized Serial PCCT Trial of Early Evolocumab After ACS | West China Hospital | Phase 4 | Recruiting | Coronary, Coronary Artery Disease | 232 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07612774) |
| May 27, 2026 | NCT07609940 | Adult Outpatient Linvoseltamab With Tocilizumab Prophylaxis to Mitigate the Risk of Cytokine Release Syndrome (CRS) | Regeneron Pharmaceuticals | Phase 4 | Recruiting | Relapsed/Refractory Multiple Myeloma (RRMM) | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07609940) |
| May 14, 2026 | NCT07588438 | Efficacy, Safety, and Tolerability of Tirzepatide in Real-World Conditions in Paraguay. | Las Rías Medical Center | Phase 4 | Recruiting | Obesity, Diabetes Mellitus, Type 2 | 160 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07588438) |
| April 30, 2026 | NCT07560046 | Combating Related Epidemics in HCV | Duke University | Phase 4 | Not yet recruiting | HIV - Human Immunodeficiency Virus, Hepatitis B Virus (HBV), HEPATITIS C (HCV) | 1,280 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07560046) |
| April 15, 2026 | NCT07531251 | Clinical Trial in Patients With Barth Syndrome- 4TAZPower | Stealth BioTherapeutics Inc. | Phase 4 | Recruiting | Barth Syndrome | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07531251) |
| April 14, 2026 | NCT07526948 | Vaginal Estradiol vs Moisturizer to Improve Postmenopausal Vaginal Aging Symptoms and the Microbiome in Women Living With HIV | Albert Einstein College of Medicine | Phase 4 | Not yet recruiting | Menopausal Complaints, Vaginal Atrophy, Genitourinary Symptoms, HIV (Human Immunodeficiency Virus), Menopause Related... | 62 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07526948) |
| April 13, 2026 | NCT07523867 | Spironolactone Alternate Dosing vs Finerenone in Elevated Potassium - K Safety Study | Hospital de Messejana Dr. Carlos Alberto Studart Gomes | Phase 4 | Not yet recruiting | Heart Failure, Diabetic Kidney Disease, Hyperkalemia | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07523867) |
| April 6, 2026 | NCT07511257 | Multicenter Trial of Antithrombotic Strategies in Acute Coronary Syndrome With Coronary Artery Ectasia | Instituto Nacional de Cardiologia Ignacio Chavez | Phase 4 | Recruiting | Coronary Artery Ectasia, Acute Coronary Syndromes (ACS), STEMI - ST Elevation Myocardial Infarction, NSTEMI - Non-ST... | 326 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07511257) |
| April 3, 2026 | NCT07510568 | Vitamin D Supplementation Among Pregnant Women in Uganda for the Prevention of Hypertensive Disorders in Pregnancy, and Other Adverse... | St Mary's Hospital, Lacor | Phase 4 | Not yet recruiting | Preeclampsia, Eclampsia, HELLP Syndrome | 1,980 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07510568) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Shenyang Northern Hospital | 2 |
| Samsung Medical Center | 2 |
| Assiut University | 2 |
| Endeavor Health | 2 |
| Aarhus University Hospital | 2 |
| Children's Hospital of Fudan University | 2 |
| China National Center for Cardiovascular Diseases | 2 |
| University of Sao Paulo General Hospital | 2 |
| Haiphong University of Medicine and Pharmacy | 1 |
| Peking University Third Hospital | 1 |
| [Novartis Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/novartis-pharmaceuticals) | 1 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 1 |
| Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz | 1 |
| University Medical Center, Kazakhstan | 1 |
| University of Missouri-Columbia | 1 |
| CAN Community Health | 1 |
| [Regeneron Pharmaceuticals](https://specstream.ai/data/clinical-trials/company/regeneron-pharmaceuticals) | 1 |
| University of Connecticut | 1 |
| University of California, San Diego | 1 |
| Las Rías Medical Center | 1 |
| Collegium Medicum w Bydgoszczy | 1 |
| Emory University | 1 |
| [RECORDATI GROUP](https://specstream.ai/data/clinical-trials/company/recordati-group) | 1 |
| Montefiore Medical Center | 1 |
| Yale University | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 27 |
| China | 21 |
| Canada | 8 |
| Spain | 6 |
| South Korea | 6 |
| Germany | 5 |
| Netherlands | 5 |
| Poland | 4 |
| Denmark | 4 |
| Brazil | 3 |
| Belgium | 3 |
| Italy | 3 |
| United Kingdom | 2 |
| Pakistan | 2 |
| France | 2 |
| Mexico | 2 |
| Egypt | 2 |
| Taiwan | 2 |
| Ireland | 1 |
| Latvia | 1 |
| Norway | 1 |
| Kazakhstan | 1 |
| Paraguay | 1 |
| Uganda | 1 |
| Japan | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Retaining wall suppliers in the United States](https://specstream.ai/data/businesses/retaining-wall-suppliers/united-states)
- [Banks in the United States](https://specstream.ai/data/businesses/banks/united-states)
- [Greek restaurants in the United States](https://specstream.ai/data/businesses/greek-restaurants/united-states)
- [Property management companies in the United States](https://specstream.ai/data/businesses/property-management-companies/united-states)
- [B2B energy and utility companies in the United States](https://specstream.ai/data/businesses/b2b-energy-and-utility-companies/united-states)
- [Fondue restaurants in the United States](https://specstream.ai/data/businesses/fondue-restaurants/united-states)
